Report Detail

Pharma & Healthcare Bacterial Vaginosis Global Clinical Trials Review, H2, 2018

  • RnM2808672
  • |
  • 10 January, 2020
  • |
  • Global
  • |
  • 159 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Bacterial Vaginosis Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, H2, 2019" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Table of Contents

    List of Tables 4

      List of Figures 5

        Report Guidance 6

          GlobalData Clinical Trials Report Coverage 7

            Clinical Trials by Region 8

              Clinical Trials and Average Enrollment by Country 9

                Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

                  Top Five Countries Contributing to Clinical Trials in Europe 13

                    Top Countries Contributing to Clinical Trials in North America 14

                      Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

                        Top Countries Contributing to Clinical Trials in Central and South America 16

                          Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 17

                            Clinical Trials by Phase in G7 Countries 19

                              Clinical Trials in G7 Countries by Trial Status 20

                                Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 22

                                  Clinical Trials by Phase in E7 Countries 24

                                    Clinical Trials in E7 Countries by Trial Status 25

                                      Clinical Trials by Phase 27

                                        In Progress Trials by Phase 28

                                          Clinical Trials by Trial Status 29

                                            Clinical Trials by End Point Status 31

                                              Subjects Recruited Over a Period of Time 32

                                                Clinical Trials by Sponsor Type 33

                                                  Prominent Sponsors 34

                                                    Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 36

                                                      Prominent Drugs 37

                                                        Latest Clinical Trials News on Bacterial Vaginosis 38

                                                          Aug 08, 2019: Dare announces presentation of positive clinical findings for vaginal administration of novel formulation of clindamycin phosphate for the treatment of bacterial vaginosis at the 2019 Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology 38

                                                            Clinical Trial Profile Snapshots 39

                                                              Appendix 158

                                                                Abbreviations 158

                                                                  Definitions 158

                                                                    Research Methodology 159

                                                                      Secondary Research 159

                                                                        About GlobalData 160

                                                                          Contact Us 160

                                                                            Source 161

                                                                            Summary:
                                                                            Get latest Market Research Reports on Bacterial Vaginosis. Industry analysis & Market Report on Bacterial Vaginosis is a syndicated market report, published as Bacterial Vaginosis Global Clinical Trials Review, H2, 2018. It is complete Research Study and Industry Analysis of Bacterial Vaginosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                            Last updated on

                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                            Purchase this Report

                                                                            $2,500.00
                                                                            $5,000.00
                                                                            $7,500.00
                                                                            1,970.00
                                                                            3,940.00
                                                                            5,910.00
                                                                            2,335.00
                                                                            4,670.00
                                                                            7,005.00
                                                                            393,300.00
                                                                            786,600.00
                                                                            1,179,900.00
                                                                            208,900.00
                                                                            417,800.00
                                                                            626,700.00
                                                                            Credit card Logo

                                                                            Related Reports


                                                                            Reason to Buy

                                                                            Request for Sample of this report